Global Vaccine Delivery Devices Market To Record Double Digit Growth Of 11.8% Over 2022-2027

October 2021 | Report Format: Electronic (PDF)

Increasing worries of institutional arrangements, entities, and important businesses in new drug distribution innovations is a critical component of increasing product consumption; additionally, multiple worldwide authorities and associations are rising expenditure on vaccination initiatives, significantly boost in the implementation of syringes free automation, growing accelerated development of science in structured delivering of therapeutic agents of immunizations including mini needles as well as electroporation, and growing utilization of micro-needles owing to safety issues, are some of the important elements propelling the market growth.

Furthermore, growing technical developments and automation in vaccine manufacturing, rising R&D efforts in the medical industry, as well as growing developing markets would provide new possibilities for the vaccine administration equipment industry during the anticipated period. North America is likely to have a leading share in the worldwide vaccine distribution systems market, due to the increased need for intranasal distribution equipment, which provides a non-invasive mode of dosage in comparison to injectable. As a result, intranasal administration devices boost the possibility for client adherence while also providing a framework for improving bioavailability characteristics.

Furthermore, owing to monetary backing from the Bill and Melinda Gates Foundation and many others in 2010, a significant rise in vaccination availability rendered vaccines accessible to billions of individuals in the United States. Moreover, owing to increased knowledge about jet injection equipment, which has decreased the significant danger of crossed infection, needle-stick wounds accidents, and are less uncomfortable to the client, the APAC region is predicted to be the leading industry for vaccine administration devices throughout the projected timeframe.

Request a Free Sample Copy: Vaccine Delivery Devices Market Report

Vaccine Delivery Devices Market Report Highlights

• PharmaJet and Abnova signed an agreement in May 2020 to produce and distribute a COVID-19 mRNA vaccine utilizing needle-free injectable techniques.
• In November 2020, Mylan NV merged with the Upjohn subsidiary of Pfizer Inc. to become Viatris, a worldwide pharmaceutical producer.
• BD (Becton, Dickinson, and Business), a major worldwide biomedical tech company, as well as Babson Diagnostics, signed a strategic alliance to expand their product range in February 2020.

VACCINE DELIVERY DEVICES MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Vaccine Delivery Devices Devices Outlook (Revenue, USD Million, 2016 - 2027)

• Jet Injectors
• Syringes
• Others

Vaccine Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2016 - 2027)

• Intramuscular Vaccination
• Intradermal Vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Vaccine Delivery Devices End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Clinics
• Hospitals
• Others

Vaccine Delivery Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players- Vaccine Delivery Devices Market

• West Pharmaceutical Services Inc.
• Vaxxas Pty Ltd.
• Theraject Inc.
• Terumo Corp.
• Smiths Medical
• Schott Ag
• Pharmajet
• Nanopass Technologies Ltd.
• Medical International Technologies (Mit Canada) Inc.
• Kindeva Drug Delivery (Formerly 3M)
• Ichor Medical Systems Inc.
• Hindustan Syringes & Medical Devices Ltd.
• Enesi Pharma
• D'antonio Consultants International Inc.
• Corium Inc.
• BD
• Apiject Systems Corp.

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of inTypeation, mined from authentic sources, into a valuable asset of the report; aiding our clients with inTypeed business decisions.

Contact Us:

Market Research Strategy

473 Mundet Place,

Ste US520501 Hillside

New Jersey 07205 United States

USA Phone: ++1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/